McGlone Suttner Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-75
Closed -$1.05K 335
2023
Q4
$1.05K Buy
+75
New +$1.04K ﹤0.01% 714

Other funds holding DVAX

McGlone Suttner Wealth Management's DVAX Position: Q1 2024 in Review

McGlone Suttner Wealth Management sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 75 shares — an estimated $1.05K sold.

McGlone Suttner Wealth Management first reported a position in DVAX in Q4 2023 and held it in 1 quarter. The position peaked at $1.05K in Q4 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • McGlone Suttner Wealth Management reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 75 Dynavax Technologies shares in Q1 2024, an estimated $1.05K.
  • McGlone Suttner Wealth Management first reported a position in Dynavax Technologies in Q4 2023 and held it in 1 quarter.
  • McGlone Suttner Wealth Management's Dynavax Technologies position peaked at $1.05K in Q4 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.